Unraveling tumor specific neoantigen immunogenicity prediction: a comprehensive analysis

Unraveling tumor specific neoantigen immunogenicity prediction: a comprehensive analysis

IntroductionIdentification of tumor specific neoantigen (TSN) immunogenicity is crucial to develop peptide/mRNA based anti-tumoral vaccines and/or adoptive T-cell immunotherapies; thus, accurate in-silico classification/prioritization proves critical for cost-effective clinical applications. Several...

Full description

Bibliographic Details
Main Authors:	Guadalupe Nibeyro, Veronica Baronetto, Juan I. Folco, Pablo Pastore, Maria Romina Girotti, Laura Prato, Gabriel Morón, Hugo D. Luján, Elmer A. Fernández
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-07-01
Series:	Frontiers in Immunology
Subjects:	immunotherapy cancer immunology neopeptide immunogenic neoantigen database immunoinformatic
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1094236/full

Similar Items

Apparent Lack of BRAFV600E Derived HLA Class I Presented Neoantigens Hampers Neoplastic Cell Targeting by CD8+ T Cells in Langerhans Cell Histiocytosis
by: Paul G. Kemps, et al.
Published: (2020-01-01)

Structural basis for T cell recognition of cancer neoantigens and implications for predicting neoepitope immunogenicity
by: Roy A. Mariuzza, et al.
Published: (2023-11-01)

Pre‐existing heterologous T‐cell immunity and neoantigen immunogenicity
by: Qibin Leng, et al.
Published: (2020-01-01)

IMPROVE: a feature model to predict neoepitope immunogenicity through broad-scale validation of T-cell recognition
by: Annie Borch, et al.
Published: (2024-04-01)

The Neoantigen Landscape of Mycosis Fungoides
by: Arunima Sivanand, et al.
Published: (2020-11-01)

ProGeo-neo: a customized proteogenomic workflow for neoantigen prediction and selection
by: Yuyu Li, et al.
Published: (2020-04-01)

OVERVIEW OF PRE-CLINICAL TECHNIQUES FOR PREDICTING THE IMMUNOGENICITY OF THERAPEUTICS IN DRUG DEVELOPEMENT
by: Clarisse Musanabaganwa, et al.
Published: (2014-03-01)

Cancer neoantigens and immunogenicity: mutation position matters
by: Aude-Hélène Capietto, et al.
Published: (2020-05-01)

Structure Based Prediction of Neoantigen Immunogenicity
by: Timothy P. Riley, et al.
Published: (2019-08-01)

Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer
by: Belén Aparicio, et al.
Published: (2022-11-01)

“Immunoinformatic Identification of T-Cell and B-Cell Epitopes From Giardia lamblia Immunogenic Proteins as Candidates to Develop Peptide-Based Vaccines Against Giardiasis”
by: Thania Garzon, et al.
Published: (2021-10-01)

Computational and Experimental Evaluation of the Immune Response of Neoantigens for Personalized Vaccine Design
by: Iker Malaina, et al.
Published: (2023-05-01)

Colorectal cancer vaccines: in silico identification of tumor-specific antigens associated with frequent HLA-I alleles in the costa rican Central Valley population
by: Diego Morazán-Fernández, et al.
Published: (2022-11-01)

Immunogenicity assessment of antileukemic agent glutaminase from Escherichia coli, Pseudomonas sp., and Bacillus sp.
by: Jyotsna Parmar, et al.
Published: (2022-01-01)

Neoantigen characteristics in the context of the complete predicted MHC class I self-immunopeptidome
by: Scott D. Brown, et al.
Published: (2019-03-01)

SIGANEO: Similarity network with GAN enhancement for immunogenic neoepitope prediction
by: Yilin Ye, et al.
Published: (2023-01-01)

Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges
by: Zhi Pang, et al.
Published: (2023-12-01)

Characterization of CD8+ T-cell responses to non-anchor-type HLA class I neoantigens with single amino-acid substitutions
by: Tomoyo Shinkawa, et al.
Published: (2021-01-01)

Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment
by: Alice Newey, et al.
Published: (2019-11-01)

Identification and Targeting of Mutant Peptide Neoantigens in Cancer Immunotherapy
by: Daniel J. Verdon, et al.
Published: (2021-08-01)

Efficacy and Safety of Actively Personalized Neoantigen Vaccination in the Management of Newly Diagnosed Glioblastoma: A Systematic Review
by: Khan M, et al.
Published: (2021-09-01)

Current Trends in Neoantigen-Based Cancer Vaccines
by: Szu-Ying Ho, et al.
Published: (2023-03-01)

Utilizing immunogenomic approaches to prioritize targetable neoantigens for personalized cancer immunotherapy
by: Ravi K. Shah, et al.
Published: (2023-12-01)

Immune-based mutation classification enables neoantigen prioritization and immune feature discovery in cancer immunotherapy
by: Peng Bai, et al.
Published: (2021-01-01)

Identification of Neoantigens in Cancer Cells as Targets for Immunotherapy
by: Masahiro Okada, et al.
Published: (2022-02-01)

NAIRscore as a biomarker for the quality of immune response to neoantigens is related with an increased overall survival in multiple myeloma
by: Xingxing Jian, et al.
Published: (2022-09-01)

Adoptive Cell Therapy Targeting Neoantigens: A Frontier for Cancer Research
by: Zhidong Wang, et al.
Published: (2020-03-01)

POTN: A Human Leukocyte Antigen-A2 Immunogenic Peptides Screening Model and Its Applications in Tumor Antigens Prediction
by: Qingqing Meng, et al.
Published: (2020-10-01)

Beyond MHC binding: immunogenicity prediction tools to refine neoantigen selection in cancer patients
by: Ibel Carri, et al.
Published: (2023-04-01)

Improvement in neoantigen prediction via integration of RNA sequencing data for variant calling
by: Bui Que Tran Nguyen, et al.
Published: (2023-09-01)

T Cell Recognition of Tumor Neoantigens and Insights Into T Cell Immunotherapy
by: Malcolm J. W. Sim, et al.
Published: (2022-02-01)

Targeting neoantigens for cancer immunotherapy
by: Xuan Zhao, et al.
Published: (2021-07-01)

Chemotherapy weakly contributes to predicted neoantigen expression in ovarian cancer
by: Timothy O’Donnell, et al.
Published: (2018-01-01)

Neoantigen‐reactive T cell: An emerging role in adoptive cellular immunotherapy
by: Yicheng Zhu, et al.
Published: (2021-06-01)

neoANT-HILL: an integrated tool for identification of potential neoantigens
by: Ana Carolina M. F. Coelho, et al.
Published: (2020-02-01)

Computational cancer neoantigen prediction: current status and recent advances
by: G. Fotakis, et al.
Published: (2021-12-01)

Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation
by: Lijin Li, et al.
Published: (2021-04-01)

Neoantigen-Reactive T Cells: The Driving Force behind Successful Melanoma Immunotherapy
by: Lindy Davis, et al.
Published: (2021-12-01)

Artificial intelligence applied in neoantigen identification facilitates personalized cancer immunotherapy
by: Yu Cai, et al.
Published: (2023-01-01)

In silico methods for immunogenicity risk assessment and human homology screening for therapeutic antibodies
by: Aimee E. Mattei, et al.
Published: (2024-12-01)